Epilepsy research
-
Multicenter Study Clinical Trial
The KEEPER trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study.
Three randomized, placebo-controlled trials have demonstrated the safety and efficacy of levetiracetam, a new antiepileptic medication, as add-on therapy for partial-onset seizures. The purpose of this study was to gather additional safety and efficacy data on levetiracetam in the real-world setting of community-based practice. ⋯ These results provide further evidence regarding the efficacy and safety of levetiracetam as adjunctive treatment for partial-onset seizures.